In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining muscle; data continue to support once or twice-yearly dosing Phas ...
Create a Physics World account to get access to all available digital issues of the monthly magazine. Your Physics World ...